CHEK2 and cancer: At the same time, in a large-scale study of BC women aged 35–59 years, who were mainly of Northern and Western European descent, PVs in CHEK2, ATM, PALB2, and PMS2 genes were the most frequent among the 25 cancer genes tested, after PVs in BRCA1/2 [26].